It would be absurd to ignore this global event, and good news about it doesn't drop every day, but we've managed to find a few glimpses. Here we go: Dutch scientists from Erasmus MC and Utrecht University found an antibody able to block infection of SARS1 and SARS2. An antibody is the organism's response to an antigen, which is found in vaccines. While an antigen is far from being manufactured and approved, the antibody can be used in medicine to prevent further COVID-19 infections. This will eventually happen after it passes human trials, which will take several months. On the same subject: The first clinical trial for a coronavirus vaccine started today in Seattle, US, as the first subject received an experimental dose. A team of Canadian scientists has successfully isolated and grown copies of the coronavirus—a major step in developing a viable vaccine, and a breakthrough in the study community. CureVac, the company Trump tried to buy a few days ago, is focusing on an mRNA-based vaccine, which can work out faster if successful. Although these are real stories from verified sources, it's better to take everything with a grain of salt. Studies don't end overnight and human trials always take a year, so patience is the word here. Meanwhile, don't lose hope, stay home, wash your hands, and keep scrolling because there is good news to illustrate. That won't change.